Emilia J. Diego - Concepedia

Author

Emilia J. Diego

Also Known As

Diego, Emilia J, E Diego, E. Diego, E.J. Diego, Emelia J. Diego, Emilia Diego, Emilia J Diego, Emilia J. Diego, Emilia Josefa Borromeo Diego, K Dickinson

124

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Pittsburgh Magee-Womens Hospital University of Pittsburgh Medical Center The University of Texas MD Anderson Cancer Center Levine Cancer Institute

About

Emilia J. Diego is an author at University of Pittsburgh specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	605
2	Health Sciences	4	4	238
3	Engineering	1	1	16
4	Nursing	1	1	27
5	Biostatistics	1	1	19

Emilia J. Diego

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The Importance of Detection of Subclinical Lymphedema for the Prevention of Breast Cancer-Related Clinical Lymphedema after Axillary Lymph Node Dissection; A Prospective Observational Study Atilla Soran, Tolga Özmen, Kandace P. McGuire, Lymphatic Research and Biology	2014	191
Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes Emilia J. Diego, Priscilla F. McAuliffe, Atilla Soran, Annals of Surgical Oncology Surgical OncologyBreast OncologyNeoadjuvant ChemotherapyMedicinePathology	2016	155
Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial Henry M. Kuerer, Benjamin D. Smith, Savitri Krishnamurthy, The Lancet Oncology Neoadjuvant Systemic TherapySurgical OncologyBreast OncologyMedicineExceptional Responders	2022	150
Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy Min Han, Arsalan Salamat, Li Zhu, Modern Pathology Surgical OncologyBreast OncologyMedicineMetaplastic Breast CarcinomaPathology	2019	91
Low Estrogen Receptor (ER)–Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy Alessandra Landmann, Daniel J. Farrugia, Li Zhu, American Journal of Clinical Pathology	2018	76
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy Giacomo Montagna, Mary M. Mrdutt, Susie X. Sun, JAMA Oncology	2024	65
Abstract GS5-05: Primary analysis of NRG-BR005, a phase II trial assessing accuracy of tumor bed biopsies in predicting pathologic complete response (pCR) in patients with clinical/radiological complete response after neoadjuvant chemotherapy (NCT) to explore the feasibility of breast-conserving treatment without surgery Mark Basik, Reena S. Cecchini, Jennifer F. De Los Santos, Cancer Research Abstract Gs5-05Surgical OncologyBreast OncologyOncologic ImagingBreast Mri	2020	42
The impact of Oncotype DX® recurrence score of paraffin-embedded core biopsy tissues in predicting response to neoadjuvant chemotherapy in women with breast cancer Atilla Soran, Rohit Bhargava, Ronald R. Johnson, Breast Disease	2016	38
Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors Daniel J. Farrugia, Alessandra Landmann, Li Zhu, Modern Pathology	2017	38
Healthcare providers’ perceived support from their organization is associated with lower burnout and anxiety amid the COVID-19 pandemic Katherine M. Reitz, Lauren Terhorst, Clair Smith, PLoS ONE	2021	37

Page 1